[HTML][HTML] Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and …
S Takao, T Nakashima, T Masuda, M Namba… - Stem Cell Research & …, 2021 - Springer
Abstract Background Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
[HTML][HTML] Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and …
S Takao, T Nakashima, T Masuda… - Stem Cell Research & …, 2021 - ncbi.nlm.nih.gov
Background Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust …
S Takao, T Nakashima, T Masuda… - Stem Cell Research …, 2021 - search.ebscohost.com
Abstract Background: Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust …
S Takao, T Nakashima, T Masuda, M Namba… - 2021 - agris.fao.org
Abstract Background Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust …
S Takao, T Nakashima, T Masuda… - Stem Cell Research …, 2021 - search.proquest.com
Background Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust …
S Takao, T Nakashima, T Masuda… - Stem Cell Research & …, 2021 - europepmc.org
Background Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust …
S Takao, T Nakashima, T Masuda, M Namba… - Stem Cell Research & …, 2021 - go.gale.com
Background Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust …
S Takao, T Nakashima, T Masuda… - Stem cell research …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
pulmonary fibrosis. However, ex vivo MSC expansion using serum poses risks of harmful …
Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and robust …
S Takao, T Nakashima, T Masuda, M Namba… - Stem Cell Research & …, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for pulmonary fibrosis …
Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for pulmonary fibrosis …
[HTML][HTML] Human bone marrow-derived mesenchymal stromal cells cultured in serum-free media demonstrate enhanced antifibrotic abilities via prolonged survival and …
S Takao, T Nakashima… - … Cell Research & …, 2021 - stemcellres.biomedcentral.com
Mesenchymal stromal cells (MSCs) are a potential therapeutic tool for pulmonary fibrosis.
However, ex vivo MSC expansion using serum poses risks of harmful immune responses or …
However, ex vivo MSC expansion using serum poses risks of harmful immune responses or …